University of California Davis Comprehensive Cancer Center P2C is a clinical research site located in Sacramento, California, United States 95817.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
University of California Davis Comprehensive Cancer Center P2C has participated in 1 clinical trials.
Therapeutic areas: Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland Hurthle Cell Carcinoma.
Sponsors: National Cancer Institute (NCI).
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of California Davis Comprehensive Cancer Center P2C has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of California Davis Comprehensive Cancer Center P2C has 1 clinical trials on record. Their work covers Refractory Differentiated Thyroid Gland Carcinoma, Refractory Thyroid Gland Follicular Carcinoma, Refractory Thyroid Gland Hurthle Cell Carcinoma.
University of California Davis Comprehensive Cancer Center P2C has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.